Literature DB >> 32485478

Reactions of cisplatin and cis-[PtI2(NH3)2] with molecular models of relevant protein sidechains: A comparative analysis.

Iogann Tolbatov1, Tiziano Marzo2, Damiano Cirri3, Chiara Gabbiani4, Cecilia Coletti1, Alessandro Marrone1, Roberto Paciotti1, Luigi Messori5, Nazzareno Re6.   

Abstract

Quite surprisingly, cisplatin and cis-[PtI2(NH3)2] were found to manifest significant differences in their reactions with the model protein lysozyme. We decided to explore whether these differences recur when reacting these two Pt compounds with other proteins. Notably, ESI-MS measurements carried out on cytochrome c nicely confirmed the reaction pattern observed for lysozyme. This prompted us to exploit a computational DFT approach to disclose the molecular basis of such behavior. We analyzed comparatively the reactions of cis-[PtCl2(NH3)2] and cis-[PtI2(NH3)2] with appropriate molecular models (Ls) of the sidechains of relevant aminoacids. We found that when Pt(II) complexes are reacted with sulfur ligands both quickly lose their halide ligands and then the resulting cis-[Pt(L)2(NH3)2] species loses ammonia upon reaction with a ligand excess. In the case of imidazole, again cis-[PtCl2(NH3)2] and cis-[PtI2(NH3)2] quickly lose their halide ligands but the resulting cis-[Pt(L)2(NH3)2] species does not lose ammonia by reaction with excess imidazole. These results imply that the two platinum complexes manifest a significantly different behavior in their reaction with representative small molecules in agreement with what observed in the case of model proteins. It follows that the protein itself must play a crucial role in triggering the peculiar reactivity of cis-[PtI2(NH3)2] and in governing the nature of the formed protein adducts. The probable reasons for the observed behavior are critically commented and discussed.
Copyright © 2020 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cis-diiodo-diamino‑platinum; Cisplatin; DFT; ESI-MS; Ligand substitution; Protein sidechain; Trans effect

Mesh:

Substances:

Year:  2020        PMID: 32485478     DOI: 10.1016/j.jinorgbio.2020.111096

Source DB:  PubMed          Journal:  J Inorg Biochem        ISSN: 0162-0134            Impact factor:   4.155


  8 in total

1.  New Platinum(II) Complexes Affecting Different Biomolecular Targets in Resistant Ovarian Carcinoma Cells.

Authors:  Mariafrancesca Hyeraci; Valeria Scalcon; Alessandra Folda; Luca Labella; Fabio Marchetti; Simona Samaritani; Maria Pia Rigobello; Lisa Dalla Via
Journal:  ChemMedChem       Date:  2021-04-06       Impact factor: 3.466

2.  Reactions of Arsenoplatin-1 with Protein Targets: A Combined Experimental and Theoretical Study.

Authors:  Iogann Tolbatov; Damiano Cirri; Matteo Tarchi; Tiziano Marzo; Cecilia Coletti; Alessandro Marrone; Luigi Messori; Nazzareno Re; Lara Massai
Journal:  Inorg Chem       Date:  2022-02-09       Impact factor: 5.165

3.  Medicinal Hypervalent Tellurium Prodrugs Bearing Different Ligands: A Comparative Study of the Chemical Profiles of AS101 and Its Halido Replaced Analogues.

Authors:  Lorenzo Chiaverini; Damiano Cirri; Iogann Tolbatov; Francesca Corsi; Ilaria Piano; Alessandro Marrone; Alessandro Pratesi; Tiziano Marzo; Diego La Mendola
Journal:  Int J Mol Sci       Date:  2022-07-06       Impact factor: 6.208

Review 4.  Strategies for the Improvement of Metal-Based Chemotherapeutic Treatments.

Authors:  Damiano Cirri; Francesco Bartoli; Alessandro Pratesi; Emma Baglini; Elisabetta Barresi; Tiziano Marzo
Journal:  Biomedicines       Date:  2021-05-04

5.  Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt3)I: A Theoretical and Experimental Study.

Authors:  Iogann Tolbatov; Damiano Cirri; Lorella Marchetti; Alessandro Marrone; Cecilia Coletti; Nazzareno Re; Diego La Mendola; Luigi Messori; Tiziano Marzo; Chiara Gabbiani; Alessandro Pratesi
Journal:  Front Chem       Date:  2020-09-18       Impact factor: 5.221

Review 6.  Computational Studies of Au(I) and Au(III) Anticancer MetalLodrugs: A Survey.

Authors:  Iogann Tolbatov; Alessandro Marrone; Cecilia Coletti; Nazzareno Re
Journal:  Molecules       Date:  2021-12-15       Impact factor: 4.411

7.  In Vitro Anti-SARS-CoV-2 Activity of Selected Metal Compounds and Potential Molecular Basis for Their Actions Based on Computational Study.

Authors:  Damiano Cirri; Tiziano Marzo; Iogann Tolbatov; Alessandro Marrone; Francesco Saladini; Ilaria Vicenti; Filippo Dragoni; Adele Boccuto; Luigi Messori
Journal:  Biomolecules       Date:  2021-12-10

8.  Simultaneous mass spectrometry analysis of cisplatin with oligonucleotide-peptide mixtures: implications for the mechanism of action.

Authors:  Farangis Mansouri; Luc Patiny; Daniel Ortiz; Laure Menin; Curtis A Davey; Fakhrossadat Mohammadi; Paul J Dyson
Journal:  J Biol Inorg Chem       Date:  2022-01-22       Impact factor: 3.358

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.